Compounds > trovafloxacin
Page last updated: 2024-08-24

trovafloxacin and Cross Infection

trovafloxacin has been researched along with Cross Infection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qadri, SM; Ueno, Y1
Cunha, BA; Domenico, P; Qadri, SM; Ueno, Y; Walters, EA1
Mandell, LA1
Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM1

Reviews

1 review(s) available for trovafloxacin and Cross Infection

ArticleYear
[The role of trovafloxacin in the treatment of nosocomial pneumonia].
    Medicina, 1999, Volume: 59 Suppl 1

    Topics: Anti-Infective Agents; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Humans; Naphthyridines; Pneumonia, Bacterial; Risk Factors

1999

Other Studies

4 other study(ies) available for trovafloxacin and Cross Infection

ArticleYear
Antibacterial activity of trovafloxacin against gram-positive blood culture isolates from nosocomial infections.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:8

    Topics: Anti-Infective Agents; Bacteremia; Cross Infection; Fluoroquinolones; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Naphthyridines

1996
Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl B

    Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin

1997
Trovafloxacin.
    The Medical letter on drugs and therapeutics, 1998, Mar-13, Volume: 40, Issue:1022

    Topics: Anti-Infective Agents; Clinical Trials as Topic; Cross Infection; Dose-Response Relationship, Drug; Drug Interactions; Fluoroquinolones; Humans; Intestinal Absorption; Naphthyridines; Streptococcus pneumoniae

1998
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
    Chemotherapy, 2001, Volume: 47, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Incidence; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Spain; Streptomycin; Vancomycin

2001